CDK4/6-Based Drug Research and Development: A Four-Year Update.

Pu MX, Xu WB, Ding L, Zhang SS, Tian LY, Gu SX

Open source

DOI
10.2174/0118715206469469260705112718
Published
2026 Jul 21
Container
Anti-cancer agents in medicinal chemistry
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2174/0118715206469469260705112718,
  title = {CDK4/6-Based Drug Research and Development: A Four-Year Update.},
  author = {Pu MX and Xu WB and Ding L and Zhang SS and Tian LY and Gu SX},
  year = {2026},
  journal = {Anti-cancer agents in medicinal chemistry},
  doi = {10.2174/0118715206469469260705112718},
  url = {https://doi.org/10.2174/0118715206469469260705112718}
}

RIS

TY  - JOUR
TI  - CDK4/6-Based Drug Research and Development: A Four-Year Update.
AU  - Pu MX
AU  - Xu WB
AU  - Ding L
AU  - Zhang SS
AU  - Tian LY
AU  - Gu SX
PY  - 2026
JO  - Anti-cancer agents in medicinal chemistry
DO  - 10.2174/0118715206469469260705112718
UR  - https://doi.org/10.2174/0118715206469469260705112718
ER  - 

APA

MX, P., WB, X., L, D., SS, Z., LY, T., & SX, G. (2026). CDK4/6-Based Drug Research and Development: A Four-Year Update.. Anti-cancer agents in medicinal chemistry. https://doi.org/10.2174/0118715206469469260705112718

Source records